TGTX logo

TGTX
TG Therapeutics Inc

21,287
Mkt Cap
$5.07B
Volume
480.00
52W High
$46.48
52W Low
$25.28
PE Ratio
11.50
TGTX Fundamentals
Price
$31.95
Prev Close
$30.45
Open
$30.40
50D MA
$33.78
Beta
1.23
Avg. Volume
1.62M
EPS (Annual)
$0.1458
P/B
8.17
Rev/Employee
$973,384.61
Loading...
Loading...
News
all
press releases
Ensign Peak Advisors Inc Sells 20,900 Shares of TG Therapeutics, Inc. $TGTX
Ensign Peak Advisors Inc trimmed its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 6.4% in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
TG Therapeutics, Inc. $TGTX Shares Sold by Intech Investment Management LLC
Intech Investment Management LLC cut its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 12.7% in the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·4d ago
News Placeholder
Fox Run Management L.L.C. Has $354,000 Stake in TG Therapeutics, Inc. $TGTX
Fox Run Management L.L.C. reduced its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 48.3% during the 2nd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·10d ago
News Placeholder
TG Therapeutics (NASDAQ:TGTX) Shares Down 5.9% - What's Next?
TG Therapeutics (NASDAQ:TGTX) Stock Price Down 5.9% - Here's What Happened...
MarketBeat·13d ago
News Placeholder
RSI Alert: TG Therapeutics (TGTX) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·14d ago
News Placeholder
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen
Wall Street Zen upgraded shares of TG Therapeutics from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·16d ago
News Placeholder
Brokers Set Expectations for TG Therapeutics FY2026 Earnings
TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2026 earnings per share (EPS) estimates for shares of TG Therapeutics in a report...
MarketBeat·18d ago
News Placeholder
Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley
TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Analysts at B. Riley issued their Q1 2026 earnings per share (EPS) estimates for shares of TG Therapeutics in a research note issued to investors...
MarketBeat·18d ago
News Placeholder
Why TG Therapeutics (TGTX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·19d ago
News Placeholder
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised
TG Therapeutics beats third-quarter estimates as a surge in Briumvi sales drives revenues up 92.8% and leads to a higher 2025 outlook.
Zacks·20d ago

Latest TGTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.